Document ID: chunk:federal_register_of_legislation:F2025C00215:schedule:3:p4
Version: federal_register_of_legislation:F2025C00215
Segment Type: schedule
Provision Reference: sch 3 (pt 4/4)
Character Range: 28980–30730

mg
Oxycodone with naloxone                                         Tablet (controlled release) containing oxycodone hydrochloride 10 mg with naloxone hydrochloride 5 mg
Oxycodone with naloxone                                         Tablet (controlled release) containing oxycodone hydrochloride 15 mg with naloxone hydrochloride 7.5 mg
Oxycodone with naloxone                                         Tablet (controlled release) containing oxycodone hydrochloride 20 mg with naloxone hydrochloride 10 mg
Oxycodone with naloxone                                         Tablet (controlled release) containing oxycodone hydrochloride 30 mg with naloxone hydrochloride 15 mg
Oxycodone with naloxone                                         Tablet (controlled release) containing oxycodone hydrochloride 40 mg with naloxone hydrochloride 20 mg
Oxycodone with naloxone                                         Tablet (controlled release) containing oxycodone hydrochloride 60 mg with naloxone hydrochloride 30 mg
Oxycodone with naloxone                                         Tablet (controlled release) containing oxycodone hydrochloride 80 mg with naloxone hydrochloride 40 mg
Tapentadol                                                      Tablet (modified release) 50 mg (as hydrochloride)
Tapentadol                                                      Tablet (modified release) 100 mg (as hydrochloride)
Tapentadol                                                      Tablet (modified release) 150 mg (as hydrochloride)
Tapentadol                                                      Tablet (modified release) 200 mg (as hydrochloride)
Tapentadol                                                      Tablet (modified release) 250 mg (as hydrochloride)